Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging

Journal of Biomedical Nanotechnology

Volumn 10, Issue 5, 2014, Pages 846-855

  Zhou, Heling ^a   Stafford, Jason H ^a   Hallac, Rami R ^a   Zhang, Liang ^a   Huang, Gang ^b   Mason, Ralph P ^a,b   Gao, Jinming ^a,b   Thorpe, Philip E ^a   Zhao, Dawen ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Breast Cancer; Iron Oxide Nanoparticle; Magnetic Resonance Imaging (MRI); Phosphatidylserine (PS); Radiation; Tumor Vasculature

Indexed keywords

BLOOD VESSELS; CELL MEMBRANES; ENDOTHELIAL CELLS; HEAT RADIATION; IONIZING RADIATION; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; MOLECULAR IMAGING; MONOCLONAL ANTIBODIES;

BREAST CANCER; HUMAN MONOCLONAL ANTIBODIES; IRON OXIDE NANOPARTICLE; PHOSPHATIDYLSERINE; POLYETHYLENE GLYCOL (PEG); TARGETED MRI CONTRAST AGENTS; TUMOR VASCULATURE; VASCULAR ENDOTHELIAL CELLS;

TUMORS;

NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; PGN 635 IMMUNOGLOBULIN F(AB')2 FRAGMENT CONJUGATED PEGYLATED SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER RADIOTHERAPY; COLLIMATOR; CONTROLLED STUDY; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR IMAGING; MOUSE; NANOPROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; RADIATION EQUIPMENT; STAINING; TUMOR VASCULARIZATION;

ANIMALS; CELL LINE, TUMOR; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICE; MICE, INBRED BALB C; MICE, NUDE; MOLECULAR IMAGING; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLSERINES; RADIOTHERAPY, CONFORMAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84897139377     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1851     Document Type: Article

References (32)

1. W. Cai and X. Chen, Multimodality molecular imaging of tumor angiogenesis. J. Nucl. Med. 49, 113S (2008).
2. A. P. Pathak, M. F. Penet, and Z. M. Bhujwalla, MR molecular imaging of tumor vasculature and vascular targets. Adv. Genet. 69, 1 (2010).
3. D. A. Sipkins, D. A. Cheresh, M. R. Kazemi, L. M. Nevin, M. D. Bednarski, and K. C. Li, Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat. Med. 4, 623 (1998).
4. M. Jin, G. Hao, X. Sun, and W. Chen, Nanoparticle-based positron emission tomography and single photon emission computed tomography imaging of cancer. Rev. Nanosci. Nanotechnol. 1, 3 (2012).
5. W. Cai, G. Niu, and X. Chen, Imaging of integrins as biomarkers for tumor angiogenesis. Curr. Pharm. Des. 14, 2943 (2008).
6. P. M. Winter, S. D. Caruthers, A. Kassner, T. D. Harris, L. K. Chinen, J. S. Allen, E. K. Lacy, H. Zhang, J. D. Robertson, S. A. Wickline, and G. M. Lanza, Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res. 63, 5838 (2003).
7. C. Khemtong, C. W. Kessinger, J. Ren, E. A. Bey, S. G. Yang, J. S. Guthi, D. A. Boothman, A. D. Sherry, and J. Gao, In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. Cancer Res. 69, 1651 (2009).
8. F. Kiessling, J. Huppert, C. Zhang, J. Jayapaul, S. Zwick, E. C. Woenne, M. M. Mueller, H. Zentgraf, M. Eisenhut, Y. Addadi, M. Neeman, and W. Semmler, RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment. Radiology 253, 462 (2009).
9. O. Schnell, B. Krebs, J. Carlsen, I. Miederer, C. Goetz, R. H. Goldbrunner, H. J. Wester, R. Haubner, G. Popperl, M. Holtmannspotter, H. A. Kretzschmar, H. Kessler, J. C. Tonn, M. Schwaiger, and A. J. Beer, Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography. Neuro Oncol 11, 861 (2009).
10. S. Ran, A. Downes, and P. E. Thorpe, Increased exposure of anionic phospholipids on the surface of tumor blood vessels. Cancer Res. 62, 6132 (2002).
11. S. Ran and P. E. Thorpe, Phosphatidylserine is a marker of tumor vasculature and a potential target for cancer imaging and therapy. Int. J. Radiat Oncol. Biol. Phys. 54, 1479 (2002).
12. X. Huang, M. Bennett, and P. E. Thorpe, A monoclonal antibody that binds anionic phospholipids on tumor blood vessels enhances the antitumor effect of docetaxel on human breast tumors in mice. Cancer Res. 65, 4408 (2005).
13. P. E. Thorpe, Vascular targeting agents as cancer therapeutics. Clin. Cancer Res. 10, 415 (2004).
14. S. Ran, J. He, X. Huang, M. Soares, D. Scothorn, and P. E. Thorpe, Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clin. Cancer Res. 11, 1551 (2005).
15. T. A. Luster, J. He, X. Huang, S. N. Maiti, A. J. Schroit, P. G. de Groot, and P. E. Thorpe, Plasma protein beta-2-glycoprotein 1 mediates interaction between the anti-tumor monoclonal antibody 3G4 and anionic phospholipids on endothelial cells. J. Biol. Chem. 281, 29863 (2006).
16. M. Jennewein, M. A. Lewis, D. Zhao, E. Tsyganov, N. Slavine, J. He, L. Watkins, V. D. Kodibagkar, S. O'Kelly, P. Kulkarni, P. P. Antich, A. Hermanne, F. Rosch, R. P. Mason, and P. E. Thorpe, Vascular imaging of solid tumors in rats with a radioactive arsenic-labeled antibody that binds exposed phosphatidylserine. Clin. Cancer Res. 14, 1377 (2008).
17. D. E. Gerber, A. T. Stopeck, L. Wong, L. S. Rosen, P. E. Thorpe, J. S. Shan, and N. K. Ibrahim, Phase I safety and pharmacokinetic study of bavituximab, a chimeric phosphatidylserine-targeting monoclonal antibody, in patients with advanced solid tumors. Clin. Cancer Res. 17, 6888 (2011).
18. D. Zhao, J. H. Stafford, H. Zhou, and P. E. Thorpe, Near-infrared optical imaging of exposed phosphatidylserine in a mouse glioma model. Transl. Oncol. 4, 355 (2011).
19. H. Zhou, K. Luby-Phelps, B. E. Mickey, A. A. Habib, R. P. Mason, and D. Zhao, Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One 4, e8051 (2009).
20. H. Zhou, M. Chen, and D. Zhao, Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model. PLoS One 8, e62238 (2013).
21. C. W. Kessinger, C. Khemtong, O. Togao, M. Takahashi, B. D. Sumer, and J. Gao, In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes. Exp. Biol. Med. (Maywood) 235, 957 (2010).
22. 4 nanoparticles and their specific targeting to integrin alpha(v)beta3-rich tumor cells. J. Am. Chem. Soc. 130, 7542 (2008).
23. J. W. Bulte and D. L. Kraitchman, Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 17, 484 (2004).
24. D. L. Thorek, A. K. Chen, J. Czupryna, and A. Tsourkas, Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann. Biomed. Eng. 34, 23 (2006).
25. R. Weissleder and M. J. Pittet, Imaging in the era of molecular oncology. Nature 452, 580 (2008).
26. L. Yang, X. H. Peng, Y. A. Wang, X. Wang, Z. Cao, C. Ni, P. Karna, X. Zhang, W. C. Wood, X. Gao, S. Nie, and H. Mao, Receptor-targeted nanoparticles for in vivo imaging of breast cancer. Clin. Cancer Res. 15, 4722 (2009).
27. M. Zhao, D. A. Beauregard, L. Loizou, B. Davletov, and K. M. Brindle, Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat. Med. 7, 1241 (2001).
28. A. K. Hammill, J. W. Uhr, and R. H. Scheuermann, Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death. Exp. Cell Res. 251, 16 (1999).
29. B. Mirnikjoo, K. Balasubramanian, and A. J. Schroit, Mobilization of lysosomal calcium regulates the externalization of phosphatidylserine during apoptosis. J. Biol. Chem. 284, 6918 (2009).
30. K. Balasubramanian and A. J. Schroit, Aminophospholipid asymmetry: A matter of life and death. Annu. Rev. Physiol. 65, 701 (2003).
31. T. Nakajima, K. Sano, M. Mitsunaga, P. L. Choyke, and H. Kobayashi, Real-time monitoring of in vivo acute necrotic cancer cell death induced by near infrared photoimmunotherapy using fluorescence lifetime imaging. Cancer Res. 72, 4622 (2012).
32. A. Tomillero and M. A. Moral, Gateways to clinical trials. Methods Find Exp. Clin. Pharmacol. 31, 661 (2009).